Feb 9th, 2026

Hims & Hers Stops Selling Wegovy Copycat Weight-Loss Pill

Novo Nordisk A/S shares rose after Hims & Hers Health Inc. agreed to stop selling a copycat version of the new Wegovy weight-loss pill following US government threats to crack down on knockoffs. Bloomberg's Sam Fazeli reports.

Top Video

Explore More

Duration:10:33

Trump Making China Great Again?

Duration:3:13

What It Will Take to Fix the Oil Market

Duration:1:42

Trump Says He'll Talk About Selling Arms to Taiwan at Xi Summit

Duration:1:46

South Africa’s Ramaphosa Says He Won’t Resign

Duration:23:44

Blackstone’s Gray on $26 Bln Bet That Felt 'Career Shortening'

Leaders with Francine Lacqua

Duration:10:38

Another Record Setting Day for US Equities | Closing Bell

The Close

Duration:2:02

KKR Injects $300 Million Into Private Credit Fund

Duration:3:08

US Citizens From Hantavirus Ship Isolated in Nebraska

Duration:1:48

Oil Jumps as Trump Rebuffs Iran’s Offer

Daybreak: Europe

Duration:2:52

JPMorgan Says Equities at All-Time Highs 'Make Sense'

Duration:2:24

Brent Has Found an 'Uneasy Equilibrium,' StanChart Says

Duration:1:29

US, Iran Wrangle Over Terms of Peace Deal

Available on:

Listen onApple TVListen onRokuListen onSamsung TVListen onFire TVListen onAndroid TVListen onRakuten TVListen onHaystack News

Watch BTV in your area:

Channel Finder
Terms of ServiceTrademarksPrivacy Policy
CareersAdvertise
Ad Choices
Help©2026 Bloomberg L.P. All Rights Reserved.